Transsexualism and osteoporosis

Experimental and Clinical Endocrinology and Diabetes

Volumn 106, Issue 4, 1998, Pages 365-368

  Schlatterer, K ^a   Auer, D P ^a   Yassouridis, A ^a   Von Werder, K ^b   Stalla, G K ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Cross gender hormone therapy; Osteoporosis; Quantitative CT; Transsexualism

Indexed keywords

CYPROTERONE ACETATE; METHYLTESTOSTERONE; SEX HORMONE;

ADULT; ARTICLE; BONE DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE SUBSTITUTION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; RISK; TRANSSEXUALISM;

EID: 0031665102     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211999     Document Type: Article

References (14)

1. Cann CE: Quantitative CT applications: comparism of current scanners. Radiol. 162: 257, 1987
2. Cann CE, Genant HK: Precise measurement of vertebral mineral content using computed tomography. J Comp Ass Tomo 4: 493-500, 1980
3. Christiansen C, Christensen MS, Larsen NE and Transbol IB: Pathophysiological mechanism of estrogen effect on bone metabolism. Dose-response relationships in early postmenopausal women. J Clin Endocrin Metab 55: 1124-1130, 1982
4. Finkelstein JS, Klibanski A, Neer RM, et al.: Increases in the bone density during treatment of men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 69: 776-783, 1989
5. Ho KK and Weissberger AJ: Impact of short-term estrogen administration on growth hormone secretion and action: distinct route-dependent effects on connective and bone tissue metabolism. J Bone Miner Res 7: 821-827, 1992
6. Hobbs CJ, Plymate SR, Rosen CJ and Adler RA: Testosterone administration increases insulin-like growth factor-1 levels in normal men. J Cli Endocrinol Metab 72: 374-381, 1993
7. Kanis JA, Beneton MNC, Gennari C et al.: Effects of anabolic steroids on cortical bone and fracture. In: Christiansen C, Riis BJ (eds.) Proceedings 1993. Aalborg, pp. 308-310, Handelstrykkeriet. Aalborg, 1993
8. Lips P, Asscheman H, Uitewaal P, Netelenbos JC and Gooren L: The effect of cross-gender hormonal treatment on bone metabolism m male-to-female transsexuals. J Bone Miner Res 4: 657-662, 1989
9. Mazess RB and Whedon D: Immobilization and bone. Calcif Tiss Int. 35: 265-267, 1983
10. Peris P, Pares A, Guanabens N, Pons F and al.: Reduced spinal and femoral bone mass and deranged bone mineral metabolism in chronic alcoholics. Alcohol and Alcoholism 27: 619-625, 1992
11. Pocock NA, Eisman JA, Yeates MG, Sambrook PN and Eberl S: Physical fitness is a major determinant of femoral neck and lumbar spine bone mineral density. J Clin Invest 78: 618-621, 1986
12. Schlauerer K, von Werder K and Stalla GK: Multistep treatment concept of transsexual patients. Exp Clin Endocrinol 104:. 413-419, 1996
13. Smith EP, Boyd J, Frank GR et al.: Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331: 1056-1061, 1994
14. Van Kesteren P, Lips P, Deville W et al.: The effect of one-year cross-sex hormonal treatment on bone metabolism and serum insulin-like growth factor-1 in transsexuals. J Clin Endocrinol Metab 81: 2227-2232, 1996